Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tyche IndustriesBOM:532384 +2.74%72 Interest Coverage is No Debt (1) as of Jun. 2026, which is 100% below its 10-year median of 4,850.31. GuruFocus rates BOM:532384 with a GF Score™ of 72/100 and a GF Value™ of ₹108.23 (Fairly Valued). The stock has 3 warning signs investors should review. Among 685 Drug Manufacturers companies, Tyche Industries ranks worse than 145985.26% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Tyche Industries's
Operating Income
for the
three
months ended in Jun. 2026 was ₹-23.2 Mil. Tyche Industries's Interest Expense for the
three
months ended in Jun. 2026 was ₹0.0 Mil.
Tyche Industries has no debt.
The higher the ratio, the stronger the company's financial strength is.
(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for Tyche Industries's Interest Coverage or its related term are showing as below:
BOM:532384's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Tyche Industries Interest Coverage Related Terms
Tyche Industries Interest Coverage Historical Data
* Premium members only.
The historical data trend for Tyche Industries's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Tyche Industries's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tyche Industries Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tyche Industries's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Tyche Industries's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
Tyche Industries (BOM:532384) has a Interest Coverage of No Debt (1) as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Tyche Industries and its competitors. This is 100% below median its historical median of 4,850.31. According to the industry distribution chart, Tyche Industries ranks #999999 out of 685 companies in the Drug Manufacturers industry.
Is Tyche Industries' Interest Coverage too high?
Tyche Industries' current Interest Coverage of No Debt (1) is 100% below median its 10-year median of 4,850.31. Based on the distribution chart, Tyche Industries ranks #999999 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tyche Industries has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tyche Industries' Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Tyche Industries ranks #999999 out of 685 companies for Interest Coverage. This places Tyche Industries in the lower half of its industry. The industry median Interest Coverage is 14.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 14.00, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Tyche Industries and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 14.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tyche Industries's current Interest Coverage is No Debt (1), which is 100% below median its own 10-year median of 4,850.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tyche Industries stock overvalued right now?
Based on GuruFocus' analysis, Tyche Industries (BOM:532384) is currently considered Fairly Valued. The stock's GF Value™ is ₹108.23, compared to a current price of ₹106.85 — trading 1.3% below its estimated fair value. The current Interest Coverage is No Debt (1), which is 100% below median its 10-year median of 4,850.31. Tyche Industries' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Tyche Industries (BOM:532384), the current Interest Coverage is No Debt (1) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tyche Industries (BOM:532384) Overvalued in 2026?
Based on GuruFocus' analysis, Tyche Industries stock appears to be undervalued.
The current stock price of ₹106.85 is trading 1.3% below its estimated GF Value™ of ₹108.23.
GuruFocus considers Tyche Industries to be Fairly Valued.
Key valuation signals for BOM:532384:
Interest Coverage: No Debt (1) (100% below median its 10-year median of 4,850.31)
GF Value™: ₹108.23 vs. price of ₹106.85 (1.3% below fair value)
No single metric tells the full story. See the BOM:532384 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tyche Industries Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing of bulk drug intermediates. Geographically, it derives a majority of its revenue from the Export business. The company is a manufacturer in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to the USA and Europe. Its business areas include API, Intermediates, Chiral Intermediates, Nutraceuticals, and CDMO. It operates in a single segment namely the manufacture of bulk drugs intermediates.
72GF Score
Get the complete analysis for BOM:532384
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532384 has been successfully added to your 
